Supporting Science in a world of COVID-19 19th February 2021

Introduction

Whilst we are still living in a world largely dominated by COVID-19, here at Baker, we feel it’s important to still continue to support those who have dedicated their careers to patient and clinical care across the globe!

As vaccines programs are rolled out in many countries, the hope for a new normality is on the horizon.

At Baker, we have been #SupportingScience since 1951 and with new vaccines, therapeutics and discoveries now worldwide, we will continue to do so now more than ever!

1. Research of Neurodegenerative Diseases

Researchers have published a study that presents new evidence regarding the key protein, ‘alpha-synuclein’ and the effect it has on the neurons in the brain. Research suggests that the ‘alpha-synuclein’ protein sticks to the inner face of the plasma membrane of nerve cells, but not to the other, a crucial new piece of information. The results of this study could unlock more research about such debilitating diseases, such as Parkinson’s disease.

source

2. ApiJect to be the Next Generation of Disposable Injectors

Following approval of the product back in November 2020, ApiJect is thought to be the next generation in disposable injectors, replacing the use of multi-dose glass vials. The US company says that the disposable injection device can be mass-produced quickly, enabling various vaccines and other medications to be delivered globally in a short space of time.

source

3. Gut Microbiome and it’s Effects on Parkinson’s Disease

A recent study found that Parkinson’s disease is associated with the changes to the gut microbiome. For example, in Parkinson’s disease, the gut bacteria’s ability to break down fat is altered, making it harder to regulate bile acid breakdown. Disruptions in this production could be a potential indicator of the condition. Therefore, treatments targeting the microbiome in the gut may help to delay the progression of Parkinson’s disease.

source

4. The University of California and Genetic Variation

New research published by the University of California found that inherited genetic variation can play a role in the overall response to cancer immunotherapy and could be affected by the genes we have carried since birth. The study also points to potential new targets that could help even more patients unleash their immune systems natural power to fight off malignant cells.

source

5. Penn State College of Medicine Discovery

Studies headed by leading scientists from Penn State College of Medicine found that the antidepressant drug, paroxetine has the potential to slow down and possibly halt cartilage degeneration. This means that the drug could be the first to be able to inhibit the pathway that leads to Osteoarthritis, making it the first treatment of its kind.

source

Stay Connected

Make sure you join us in #SupportingScience across all of our social media channels!

Sources